Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Oliver Wyman

Why Truth Matters During A Politicized Public Emergency

Strategies to be a leader who people trust and turn to for guidance and support in tough times.

What's Preventing Progress on Women in Leadership?

Women are still passed over for the most senior leadership roles, with only one in four executives female.

While many partnerships fail to deliver real economic value, here's how one CEO broke through.

CEO, UW Health
Partner, Health and Life Sciences, Oliver Wyman

Hospitals nationwide could near collapse as the pandemic straps them of necessary resources.

Partner & Co-Head – Risk & Public Policy, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Six Predictions for an Industry in Transformation

Welltok and Oliver Wyman discuss why this year is healthcare's watershed moment and what may unfold in 2021.

Chairman of the Board, Welltok
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Let the Survival of the Fittest Begin

How healthcare leaders can better understand what makes their businesses tick amid factors they can’t control.  

Principal, Health and Life Sciences, Oliver Wyman
Partner, Financial Services, Oliver Wyman

Featured in The Dallas Morning News

Executives who care about diversity should examine the track in their companies to senior management.

Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

Five takeaways from this year's Oliver Wyman Health Innovation Summit.

CEO, Motive Medical Intelligence

Health Plan Leaders Discuss Digital Health’s Potential

During a recent webinar, health plans shared how they're identifying and implementing digital innovations for today's world and the future.

A Singapore Case Study

Singapore is the world's second-fastest aging country. Opportunities for digital, consumer-centric strategies aim to make aging-in-place the norm.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe